section name header

Y-Site Injection Compatibility (1:1 Mixture)

Remifentanil HCl

(Mfr: HOS)(Conc: 0.25 mg/mLn)

I

Ceftobiprole medocaril sodium

(Mfr: JJ)(Conc: 2.67 mg/mLa,b)

Remarks:

Increase in measured haze and subvisible microparticles

Ref:

4128,4129